Named Bioactive Compounds · Compound
Zeaxanthin (3R,3'R,6'R)-beta,epsilon-carotene-3,3'-diol)
Moderate Evidencecarotenoid
Hermetica Superfood Encyclopedia
Zeaxanthin is a xanthophyll carotenoid that concentrates in the fovea centralis of the retina, where it forms part of the macular pigment alongside lutein. It absorbs high-energy blue light (400–500 nm) and quenches reactive oxygen species, protecting photoreceptor cells from oxidative damage.
Zeaxanthin is a naturally occurring xanthophyll carotenoid (C₄₀H₅₆O₂) synthesized in plants and microorganisms, serving as the primary pigment in corn, paprika, saffron, and goji berries. It can be extracted from marigold (Tagetes erecta) flowers via hexane extraction and saponification, or produced synthetically through the Wittig reaction, yielding 96-98% trans-(3R,3'R)-zeaxanthin.
The provided research dossier does not contain specific human clinical trials, randomized controlled trials, meta-analyses, or PubMed PMIDs. The available sources focus on chemical characterization, biosynthesis pathways, and natural occurrence rather than clinical efficacy data.
No clinically studied dosage ranges, standardization methods, or dosing protocols for zeaxanthin formulations were provided in the research dossier. Consult a healthcare provider before starting any new supplement.
Zeaxanthin (C₄₀H₅₆O₂, MW 568.87 g/mol) is a oxygenated carotenoid (xanthophyll) and is one of the two primary macular pigments in the human retina. It is a lipophilic, non-provitamin A carotenoid (unlike beta-carotene, it has no vitamin A activity). Key biochemical and nutritional details: • Structure: (3R,3'R,6'R)-β,ε-carotene-3,3'-diol; distinguished from lutein by the position of a double bond in one of its end rings (β-ring vs ε-ring), making it a structural isomer of lutein. Contains 11 conjugated double bonds responsible for its yellow-orange pigmentation and light-absorbing/antioxidant properties. • Dietary concentrations: Found in yellow/orange vegetables and fruits — notably corn/maize (approximately 500–800 µg per 100 g), orange bell peppers (up to ~1,600 µg per 100 g), goji berries (Lycium barbarum, one of the richest sources at ~2,000–56,000 µg per 100 g depending on variety), egg yolks (~200–500 µg per yolk, highly bioavailable due to lipid matrix), and dark leafy greens in smaller amounts relative to lutein. • Typical dietary intake: Average Western diet provides roughly 1–2 mg/day combined lutein + zeaxanthin, with zeaxanthin comprising approximately 20–25% of that total (~0.2–0.5 mg/day); supplementation studies (e.g., AREDS2) used 2 mg zeaxanthin combined with 10 mg lutein daily. • Bioavailability: As a fat-soluble compound, absorption is significantly enhanced by co-ingestion with dietary lipids (2–5 fold increase with ~10–15 g fat per meal). Bioavailability from egg yolks is notably higher (~200–300% greater absorption) than from plant sources or supplements due to the lipid-rich yolk matrix. Absorption occurs in the small intestine via passive diffusion and facilitated transport (involving SR-BI and CD36 receptors), incorporated into chylomicrons, transported via lipoproteins (primarily HDL and LDL), and selectively accumulated in the macula via binding proteins StARD3 (for lutein) and GSTP1 (preferentially for zeaxanthin). • Meso-zeaxanthin: A stereoisomer (3R,3'S-meso-zeaxanthin) is formed endogenously in the retina by enzymatic conversion of lutein and concentrates at the very center of the fovea; dietary meso-zeaxanthin is also found in certain fish skins and shrimp. • Serum concentrations: Typical fasting serum levels range from 0.02–0.10 µmol/L; levels are dose-responsive to supplementation. • Antioxidant capacity: Possesses strong singlet oxygen quenching ability (rate constant ~1.0 × 10¹⁰ M⁻¹s⁻¹), superior to many other carotenoids in membrane-stabilizing antioxidant activity due to its perpendicular orientation spanning the lipid bilayer with hydroxyl groups anchored at both membrane surfaces. • Peak light absorption: λmax ~450–454 nm in organic solvents (blue light range 400–500 nm), enabling selective filtration of phototoxic short-wavelength visible light. • Stability considerations: Susceptible to oxidative degradation, heat, and light; cooking with moderate heat and fat generally maintains or improves bioaccessibility, though prolonged high-temperature processing can cause isomerization and degradation. • No established RDA/DRI exists; however, intakes of 2 mg/day zeaxanthin (along with 10 mg/day lutein) have been used in major clinical supplementation trials. Toxicity is very low — no adverse effects reported at supplemental doses up to 20 mg/day in clinical studies.
Zeaxanthin accumulates in the retinal pigment epithelium and photoreceptor axons where it directly absorbs blue-wavelength light, reducing phototoxic damage to rhodopsin and cone photoreceptors. As a lipophilic antioxidant, it quenches singlet oxygen and neutralizes lipid peroxyl radicals within photoreceptor outer segment membranes, protecting polyunsaturated fatty acids like DHA from oxidation. It also interacts with the zeaxanthin-binding protein GSTP1 (glutathione S-transferase pi 1) in the macula, which facilitates selective tissue accumulation and may modulate local oxidative stress responses.
The Age-Related Eye Disease Study 2 (AREDS2), a randomized controlled trial of 4,203 participants over 5 years, found that supplementation with 10 mg lutein and 2 mg zeaxanthin reduced progression to advanced age-related macular degeneration (AMD) by approximately 26% compared to placebo in individuals with low dietary intake. Smaller RCTs (n=40–120) using 8–20 mg/day zeaxanthin for 6–12 months have demonstrated measurable increases in macular pigment optical density (MPOD) as assessed by heterochromatic flicker photometry. Evidence for cognitive and skin photoprotection benefits remains preliminary, based largely on observational studies and short-term trials with surrogate endpoints. Overall evidence for AMD risk reduction is considered moderate-to-strong, while evidence for other claimed benefits remains insufficient for firm conclusions.
Zeaxanthin is generally recognized as safe at typical supplemental doses of 2–20 mg/day, with the primary reported side effect being carotenodermia (reversible yellowing of skin) at high prolonged intakes. No significant drug interactions have been established, though concurrent use with cholesterol-lowering medications like cholestyramine or orlistat may reduce zeaxanthin absorption due to impaired fat-soluble nutrient uptake. Smokers should exercise caution, as high-dose beta-carotene supplementation has been linked to increased lung cancer risk in this population, and while zeaxanthin is structurally distinct, the caution is often extended broadly to carotenoid supplements. Data on safety during pregnancy and lactation are limited, and supplementation beyond dietary levels is generally not recommended without medical guidance during these periods.
